What is Re-gen Active Lab?
Re-gen Active Lab is an FDA-registered tissue establishment that specializes in the manufacturing of biomolecule-rich products derived from human umbilical cord and amniotic membrane. The company is committed to rigorous donor screening and adherence to regulatory standards, ensuring the production of high-quality, safe biomolecules including exosomes, proteins, and growth factors. Operating under strict environmental controls and partnering with AABB-accredited cord banks, Re-gen Active Lab prioritizes safety, consistency, and quality in its regenerative science offerings.
How much funding has Re-gen Active Lab raised?
Re-gen Active Lab has raised a total of $2.3M across 2 funding rounds:
Debt
$24K
Other Financing Round
$2.3M
Debt (2021): $24K with participation from PPP
Other Financing Round (2024): $2.3M, investors not publicly disclosed
Key Investors in Re-gen Active Lab
PPP
Public-Private Partnership
What's next for Re-gen Active Lab?
The recent major strategic investment indicates Re-gen Active Lab is poised for significant expansion and further development within the regenerative medicine market. This capital infusion is likely to fuel advancements in product research, manufacturing capabilities, and market penetration. The company's focus on high-quality biomolecules positions it for continued growth and leadership in a rapidly evolving scientific landscape.
See full Re-gen Active Lab company page
